Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry.
Kathrin PahmeierSilke NeusserChristian HammJohannes KastnerJochen WöhrleRalf ZahnStephan AchenbachJulinda MehilliTommaso GoriChristoph NaberHolger NefTill NeumannGert RichardtAxel SchmermundChristoph ClaasThomas RiemerJanine Biermann-Stallwitznull nullPublished in: BMC cardiovascular disorders (2022)
Following coronary revascularization with BVS strong decrease in self-reported angina frequency and increase of self-reported quality of life were observed with continuous improvements over two years of follow-up. Trial registration ClinicalTrials.gov Identifier: NCT02066623.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- coronary artery
- coronary artery bypass grafting
- phase iii
- study protocol
- phase ii
- clinical trial
- tissue engineering
- acute coronary syndrome
- heart failure
- newly diagnosed
- transcatheter aortic valve replacement
- left ventricular
- placebo controlled
- aortic valve